Invesco
TRVI icon

Invesco’s Trevi Therapeutics TRVI Stock Holding History

Invesco’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.21M Sell
352,984
-145,942
-29% -$1.63M ﹤0.01% 2264
2025
Q4 		$6.25M Buy
498,926
+15,856
+3% +$183K ﹤0.01% 2132
2025
Q3 		$4.42M Buy
483,070
+160,731
+50% +$1.21M ﹤0.01% 2284
2025
Q2 		$1.76M Sell
322,339
-530,646
-62% -$3.3M ﹤0.01% 2617
2025
Q1 		$5.37M Buy
852,985
+829,364
+3,511% +$3.96M ﹤0.01% 2115
2024
Q4 		$97.3K Buy
23,621
+4,133
+21% +$13.2K ﹤0.01% 3628
2024
Q3 		$65.1K Sell
19,488
-235
-1% -$699 ﹤0.01% 3660
2024
Q2 		$58.8K Sell
19,723
-165
-0.8% -$458 ﹤0.01% 3803
2024
Q1 		$68.6K Hold
19,888
– – ﹤0.01% 3779
2023
Q4 		$26.6K Buy
19,888
+3,842
+24% +$5.82K ﹤0.01% 3788
2023
Q3 		$35K Hold
16,046
– – ﹤0.01% 3821
2023
Q2 		$38.4K Buy
+16,046
New +$40.4K ﹤0.01% 3833

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return